5.1 ANAKINRA 100 mg 0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of Application - Periodic fever - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-03-16 01:05:14 Rare diseases Rheumatology Immunosuppressants Anakinra Cryopyrin-associated periodic syndrome Arthritis Familial cold urticaria Muckle–Wells syndrome Neonatal onset multisystem inflammatory disease Health Medicine Autoinflammatory syndromes		5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 203,72 KB Share Document on Facebook

	Public Summary Document – November 2014 PBAC Meeting 5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; DocID: 12wgH - View Document
	5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of Application DocID: 12oEM - View Document
	OPEN Citation: Cell Death and Disease[removed], e644; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis DocID: ZAEE - View Document
	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: DocID: E8TT - View Document
	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: DocID: zsan - View Document